CELL THERAPY DESIGN AND DEVELOPMENT AT SCALE
HIGH-THROUGHPUT & HIGH-DIMENSIONAL MULTIPLEXING² SCREENS
Traditional cell therapy development faces a trade-off between in vitro approaches that are fast but inaccurate OR in vivo approaches that are high quality but slow and expensive.
Waypoint's platform allows both depth AND breadth - speed without compromising in vivo relevance and quality, and our spatial biology technology allows us to measure both cell autonomous and non-autonomous (cell-cell, cell-environment) effects. Our approach points the way to a new paradigm in cell therapy design and development.
Leveraging advances in computer vision, in silico protein design, and pooled screening, we can achieve groundbreaking deep phenotyping across a multitude of cell therapy designs, using spatial biology profiling to rank order and select the most optimized cell therapies.